No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 43, Issue 9, 2006, Pages

  Plachouras, D ^a   Giannitsioti, E ^a   Athanassia, S ^a   Kontopidou, F ^a   Papadopoulos, A ^a   Kanellakopoulou, K ^a   Giamarellou, H ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; LINEZOLID; OXAZOLIDINONE DERIVATIVE; PYRIDOXINE;

ANEMIA; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; THROMBOCYTOPENIA;

ACETAMIDES; ANEMIA; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OXAZOLIDINONES; PYRIDOXINE; THROMBOCYTOPENIA;

MLCS; MLOWN;

EID: 33750117940     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/508280     Document Type: Article

References (0)